The Cost Effectiveness of Coronary CT Angiography and the Effective Utilization of CT-Fractional Flow Reserve in the Diagnosis of Coronary Artery Disease
- PMID: 36661920
- PMCID: PMC9863924
- DOI: 10.3390/jcdd10010025
The Cost Effectiveness of Coronary CT Angiography and the Effective Utilization of CT-Fractional Flow Reserve in the Diagnosis of Coronary Artery Disease
Abstract
Given the high global disease burden of coronary artery disease (CAD), a major problem facing healthcare economic policy is identifying the most cost-effective diagnostic strategy for patients with suspected CAD. The aim of this review is to assess the long-term cost-effectiveness of coronary computed tomography angiography (CCTA) when compared with other diagnostic modalities and to define the cost and effective diagnostic utilization of computed tomography-fractional flow reserve (CT-FFR). A search was conducted through the MEDLINE database using PubMed with 16 of 119 manuscripts fitting the inclusion and exclusion criteria for review. An analysis of the data included in this review suggests that CCTA is a cost-effective strategy for both low risk acute chest pain patients presenting to the emergency department (ED) and low-to-intermediate risk stable chest pain outpatients. For patients with intermediate-to-high risk, CT-FFR is superior to CCTA in identifying clinically significant stenosis. In low-to-intermediate risk patients, CCTA provides a cost-effective diagnostic strategy with the potential to reduce economic burden and improve long-term health outcomes. CT-FFR should be utilized in intermediate-to-high risk patients with stenosis of uncertain clinical significance. Long-term analysis of cost-effectiveness and diagnostic utility is needed to determine the optimal balance between the cost-effectiveness and diagnostic utility of CT-FFR.
Keywords: cardiovascular heart disease; coronary artery disease (CAD); coronary computed tomography angiography (CCTA); cost analysis; cost-effectiveness analysis (CEA); ischemic heart disease.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Smith S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., Grundy S.M., Hiratzka L., Jones D., Krumholz H.M., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;11:2363–2372. doi: 10.1161/CIRCULATIONAHA.106.174516. - DOI - PubMed
-
- De Beule T., Vanhoenacker P., De Booij M., Ardies L., Bladt O. Cost effectiveness of multi detector ct angiography of the coronary arteries for the diagnosis of suspected non-st elevation acute coronary syndrome (NSTE-ACS) in the emergency department. Mathematical analysis with a decision model. JBR-BTR. 2010;93:285. doi: 10.5334/jbr-btr.341. - DOI - PubMed
-
- Berger A., Simpson A., Bhagnani T., Leeper N.J., Murphy B., Nordstrom B., Ting W., Zhao Q., Berger J.S. Incidence and cost of major adverse cardiovascular events and major adverse limb events in patients with chronic coronary artery disease or peripheral artery disease. Am. J. Cardiol. 2019;123:1893–1899. doi: 10.1016/j.amjcard.2019.03.022. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous